Use of Sorafenib in Two Metastatic Renal Cell Cancer Patients with End-Stage Renal Impairment Undergoing Replacement HemodialysisElisa Ferraris, Camillo Porta, Ilaria Imarisio et al.|Tumori Journal|2009Cited by 17
7151 Safety and treatment (trx) patterns of multikinase inhibitors (MKI) in patients (pts) with metastatic renal cell carcinoma (mRCC) in ItalyPamela Di Cesare, M.S. Duh, Camillo Porta et al.|European Journal of Cancer Supplements|2009Cited by 0